نتائج البحث 151-160 من 4777 لعملية البحث عن immunosuppressant drugs
The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...
Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Nov. 1, 2020. SAMe. Facts & Comparisons eAnswers. https://www.wolterskluwercdi ...
The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all have ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
Drugs such as sapanisertib may stop the growth or shrink tumor cells by ... Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin ...
Drugs such as sapanisertib may stop the growth or shrink tumor cells by ... drug combinations to guide precision cancer medicine decision-making with a ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
التجارب السريرية · Assessing Breast Cancer Risk Perception in Hispanic, Black, and Black Hispanic Women · A Study to Compare Treatment With the Drug Selumetinib ...
Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells ...
... drugs for diagnosing and treating aggressive tumor types or neoplastic processes. Genomic analyses mean looking at the genome, or all the DNA in a cell (DNA ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.